Where can I buy the original drug Sotorasibu in China?
Sotorasib is a targeted drug used to treat KRAS G12C mutation-positive non-small cell lung cancer (NSCLC). It is not currently available in China, so domestic patients cannot purchase it directly. Since the drug has not yet been approved to enter the Chinese market, patients need to obtain it through overseas channels. In overseas markets, both the original drug and generic drugs of sotorasibu are on the market, and patients can choose to purchase them according to their needs.
In overseas markets, the original drug of Sotorasibu mainly includes the European version and the Hong Kong version. Due to its high research and development costs, original drugs are usually more expensive, with the price of each box being around tens of thousands of yuan. This price is obviously a heavy burden for patients, especially those who need to use this drug for a long time. Therefore, the high price of originator drugs often forces many patients to consider more economical alternatives.
In comparison, the price of generic drugs of sotorasibu in overseas markets is more affordable. Taking the generic drug of Sotorasibu produced in Laos as an example, the price of generic drugs produced by Lao Lucius and Lao Big Bear has been significantly reduced recently. The price of 120mg*56 tablets has dropped to more than 1,000 yuan. This price is much lower than the original drug, which greatly reduces the financial pressure on patients who need this drug. In addition, the ingredients of generic drugs in Laos are basically the same as those of the original drugs, so their therapeutic effects are similar to those of the original drugs, and patients can use them with confidence.
In general, although sotorasibu is not yet available in China, patients can still purchase the drug through overseas channels. For those patients with limited financial conditions, choosing generic drugs, especially those from Laos, is a relatively more affordable option. Although generic drugs are cheap, patients should ensure that they obtain the drugs through formal channels when purchasing to ensure the quality and efficacy of the drugs.
Reference materials:https://www.lumakras.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)